NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising cream may help kids with vitiligo regain skin color
Disease control Recruiting nowThis study tests a cream called ruxolitinib in 180 children with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely bring back color, especially on the face. Participants will apply the cream daily for about a year…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
Promising new combo for vitiligo: can a drug boost light Therapy's power?
Disease control Recruiting nowThis study tests whether adding an investigational drug called Melanotan II to standard light therapy helps restore skin color in adults with stable vitiligo. About 60 participants will receive either the drug or a placebo along with light treatments. The goal is to see if the co…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Can a Once-Daily pill bring back lost skin pigment?
Disease control Recruiting nowThis study tests a daily pill called zasocitinib for adults with nonsegmental vitiligo, a condition where the immune system attacks pigment cells, causing white patches. About 200 participants will receive either the drug or a placebo for up to a year. The goal is to see if the d…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New cream could help kids with vitiligo regain skin color
Disease control Recruiting nowThis study tests a cream called ruxolitinib to see if it can safely help children aged 6 to 12 with vitiligo regain skin color on their face and body. About 250 children will use the cream or a placebo for several months. The goal is to measure how much skin color returns, especi…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 06, 2026 16:01 UTC